These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28382303)

  • 1. Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC.
    Prelaj A; Rebuzzi SE; Del Bene G; Giròn Berrìos JR; Emiliani A; De Filippis L; Prete AA; Pecorari S; Manna G; Ferrara C; Rossini D; Longo F
    ERJ Open Res; 2017 Jan; 3(1):. PubMed ID: 28382303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
    Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
    J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
    Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
    Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases.
    Atieh T; Huang CH
    Front Oncol; 2021; 11():667468. PubMed ID: 34178652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic cranial irradiation in small cell lung cancer: A single institution experience.
    Nicholls L; Keir GJ; Murphy MA; Mai T; Lehman M
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):415-420. PubMed ID: 27453519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and treatment outcomes of resected large cell neuroendocrine carcinoma of the lung.
    Moon JY; Choi SH; Kim TH; Lee J; Pyo JH; Kim YT; Lee SJ; Yoon HI; Cho J; Lee CG
    Radiat Oncol J; 2021 Dec; 39(4):288-296. PubMed ID: 34986550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis.
    Cai Z; Gu X; Xie J; Cheng D; Chen J; Cheng J; Ye J; Lv T
    Transl Lung Cancer Res; 2023 Oct; 12(10):1987-2000. PubMed ID: 38025813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between Advanced Large Cell Neuroendocrine Carcinoma and Advanced Small Cell Lung Cancer: A Propensity Score Matching Analysis.
    Yang W; Wang W; Li Z; Wu J; Xu X; Chen C; Ye X
    J Cancer; 2023; 14(9):1541-1552. PubMed ID: 37325062
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-World Efficacy and Safety of Thoracic Radiotherapy after First-Line Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer.
    Xie Z; Liu J; Wu M; Wang X; Lu Y; Han C; Cong L; Li J; Meng X
    J Clin Med; 2023 Jun; 12(11):. PubMed ID: 37298023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
    Paz-Ares L; Dvorkin M; Chen Y; Reinmuth N; Hotta K; Trukhin D; Statsenko G; Hochmair MJ; Özgüroğlu M; Ji JH; Voitko O; Poltoratskiy A; Ponce S; Verderame F; Havel L; Bondarenko I; Kazarnowicz A; Losonczy G; Conev NV; Armstrong J; Byrne N; Shire N; Jiang H; Goldman JW;
    Lancet; 2019 Nov; 394(10212):1929-1939. PubMed ID: 31590988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
    Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L
    Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
    Le Treut J; Sault MC; Lena H; Souquet PJ; Vergnenegre A; Le Caer H; Berard H; Boffa S; Monnet I; Damotte D; Chouaid C
    Ann Oncol; 2013 Jun; 24(6):1548-52. PubMed ID: 23406729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy.
    Sun A; Durocher-Allen LD; Ellis PM; Ung YC; Goffin JR; Ramchandar K; Darling G
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):658-666. PubMed ID: 30007803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
    Kamath SS; McCarley DL; Zlotecki RA
    Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
    Patrice GI; Lester-Coll NH; Yu JB; Amdahl J; Delea TE; Patrice SJ
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):97-106. PubMed ID: 29029885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy.
    Giuliani ME; Atallah S; Sun A; Bezjak A; Le LW; Brade A; Cho J; Leighl NB; Shepherd FA; Hope AJ
    Clin Lung Cancer; 2011 Nov; 12(6):375-9. PubMed ID: 21729647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era?
    Nesbit EG; Leal TA; Kruser TJ
    Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S153-S162. PubMed ID: 31673520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
    Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
    Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.